| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |